Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
Clinical trial NCT02625610 · COMPLETED
Trial details
- NCT number
- NCT02625610
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-24
- Primary completion
- 2019-09-13
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.